Table 1 Baseline patient characteristics.
Virus+ with myocarditis | Virus+ without myocarditis | Virus– without myocarditis | Pa | |
|---|---|---|---|---|
n | 4 | 26 | 11 | |
Age (years) | 60 (55–64) | 71 (33–>89) | 62 (21–>89) | 0.40 |
Male sex | 2 (50) | 19 (73) | 6 (55) | 0.43 |
BMI (kg/m2) | 33 (29–36) | 30 (20–70) | 32 (22–60) | 0.36 |
Caucasian ethnicity | 4 (100) | 16 (62) | 3 (27) | 0.03 |
Hypertension | 2 (50) | 18 (69) | 7 (64) | 0.74 |
Diabetes mellitus | 2 (50) | 9 (35) | 3 (27) | 0.71 |
Hyperlipidemia | 1 (25) | 13 (50) | 3 (27) | 0.34 |
History of CAD | 0 (0) | 2 (8) | 0 (0) | 0.55 |
History of autoimmune disease | 0 (0) | 3 (12) | 1 (9) | 0.77 |
Statin | 1 (25) | 12 (48), n = 25 | 3 (27) | 0.41 |
ACE inhibitor | 1 (25) | 2 (8), n = 25 | 2 (18) | 0.51 |
Calcium channel blocker | 0 (0) | 4 (16), n = 25 | 1 (9) | 0.62 |
Beta-blocker | 1 (25) | 9 (36), n = 25 | 4 (36) | 0.91 |
Aspirin | 0 (0) | 10 (40), n = 25 | 2 (18) | 0.16 |
History of smoking (current or former) | 2 (67), n = 3 | 13 (50) | 4 (40), n = 10 | 0.31 |
Baseline creatinine (mg/dL) | 1.1, n = 1 | 1.0 (0.6–1.6), n = 19 | 1.1 (0.8–2.9), n = 5 | 0.74 |
Baseline BUN (mg/dL) | 19, n = 1 | 17 (11–62), n = 17 | 19 (8–27), n = 5 | 0.88 |
